273 related articles for article (PubMed ID: 25146075)
1. Health-related self-perceptions over time and provider-based Complementary and Alternative Medicine (CAM) use in people with inflammatory bowel disease or arthritis.
Sirois FM
Complement Ther Med; 2014 Aug; 22(4):701-9. PubMed ID: 25146075
[TBL] [Abstract][Full Text] [Related]
2. The Manitoba Inflammatory Bowel Disease Cohort Study: a prospective longitudinal evaluation of the use of complementary and alternative medicine services and products.
Rawsthorne P; Clara I; Graff LA; Bernstein KI; Carr R; Walker JR; Ediger J; Rogala L; Miller N; Bernstein CN
Gut; 2012 Apr; 61(4):521-7. PubMed ID: 21836028
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors of complementary and alternative medicine use for patients with inflammatory bowel disease in Korea.
Park DI; Cha JM; Kim HS; Park HJ; Shin JE; Hong SN; Hong SS; Kim WJ
Complement Ther Med; 2014 Feb; 22(1):87-93. PubMed ID: 24559822
[TBL] [Abstract][Full Text] [Related]
4. Provider-based complementary and alternative medicine use among three chronic illness groups: associations with psychosocial factors and concurrent use of conventional health-care services.
Sirois FM
Complement Ther Med; 2008 Apr; 16(2):73-80. PubMed ID: 18514908
[TBL] [Abstract][Full Text] [Related]
5. Characterisation of complementary and alternative medicine use and its impact on medication adherence in inflammatory bowel disease.
Weizman AV; Ahn E; Thanabalan R; Leung W; Croitoru K; Silverberg MS; Steinhart AH; Nguyen GC
Aliment Pharmacol Ther; 2012 Feb; 35(3):342-9. PubMed ID: 22176478
[TBL] [Abstract][Full Text] [Related]
6. Complementary and alternative medicine use by Canadian patients with inflammatory bowel disease: results from a national survey.
Hilsden RJ; Verhoef MJ; Best A; Pocobelli G
Am J Gastroenterol; 2003 Jul; 98(7):1563-8. PubMed ID: 12873578
[TBL] [Abstract][Full Text] [Related]
7. Impact of complementary and alternative medicine on the quality of life in inflammatory bowel disease: results from a French national survey.
Abitbol V; Lahmek P; Buisson A; Olympie A; Poupardin C; Chaussade S; Lesgourgues B; Nahon S
Eur J Gastroenterol Hepatol; 2014 Mar; 26(3):288-94. PubMed ID: 24407360
[TBL] [Abstract][Full Text] [Related]
8. Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease.
Lakatos PL; Czegledi Z; David G; Kispal Z; Kiss LS; Palatka K; Kristof T; Nagy F; Salamon A; Demeter P; Miheller P; Szamosi T; Banai J; Papp M; Bene L; Kovacs A; Racz I; Lakatos L
J Crohns Colitis; 2010 Sep; 4(3):283-90. PubMed ID: 21122517
[TBL] [Abstract][Full Text] [Related]
9. Complementary and alternative medicine in patients with inflammatory bowel disease: A survey performed in a tertiary center in Chile.
Fernández A; Simian D; Quera R; Flores L; Ibáñez P; Lubascher J; Figueroa C; Kronberg U; Pizarro G; Fluxá D
Complement Ther Med; 2018 Oct; 40():77-82. PubMed ID: 30219473
[TBL] [Abstract][Full Text] [Related]
10. Use of complementary and alternative medicine by older patients with arthritis: a population-based study.
Kaboli PJ; Doebbeling BN; Saag KG; Rosenthal GE
Arthritis Rheum; 2001 Aug; 45(4):398-403. PubMed ID: 11501729
[TBL] [Abstract][Full Text] [Related]
11. Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: perceived stress is a potential indicator for CAM use.
Langhorst J; Anthonisen IB; Steder-Neukamm U; Luedtke R; Spahn G; Michalsen A; Dobos GJ
Complement Ther Med; 2007 Mar; 15(1):30-7. PubMed ID: 17352969
[TBL] [Abstract][Full Text] [Related]
12. The Incidence of self-prescribed oral complementary and alternative medicine use by patients with gastrointestinal diseases.
Kong SC; Hurlstone DP; Pocock CY; Walkington LA; Farquharson NR; Bramble MG; McAlindon ME; Sanders DS
J Clin Gastroenterol; 2005 Feb; 39(2):138-41. PubMed ID: 15681910
[TBL] [Abstract][Full Text] [Related]
13. Treatment appraisals and beliefs predict adherence to complementary therapies: a prospective study using a dynamic extended self-regulation model.
Bishop FL; Yardley L; Lewith GT
Br J Health Psychol; 2008 Nov; 13(Pt 4):701-18. PubMed ID: 17961294
[TBL] [Abstract][Full Text] [Related]
14. Complementary and alternative medicine use for arthritis pain in 2 Chicago community areas.
Feinglass J; Lee C; Rogers M; Temple LM; Nelson C; Chang RW
Clin J Pain; 2007; 23(9):744-9. PubMed ID: 18075399
[TBL] [Abstract][Full Text] [Related]
15. Predictors of alternative and complementary medicine use in inflammatory bowel disease: do measures of conventional health care utilization relate to use?
Burgmann T; Rawsthorne P; Bernstein CN
Am J Gastroenterol; 2004 May; 99(5):889-93. PubMed ID: 15128356
[TBL] [Abstract][Full Text] [Related]
16. The use of complementary and alternative medicine in an Irish cohort of people with an iatrogenic hepatitis C infection: results from a health and lifestyle survey.
Coughlan BM; Thornton LM; Murphy N; Tait MA; Flanagan PC; Kenny-Walsh EE; O'Lorcain PP
Complement Ther Med; 2014 Aug; 22(4):683-9. PubMed ID: 25146073
[TBL] [Abstract][Full Text] [Related]
17. Use of complementary and alternative therapies by patients self-reporting arthritis or rheumatism: results from a nationwide canadian survey.
Fautrel B; Adam V; St-Pierre Y; Joseph L; Clarke AE; Penrod JR
J Rheumatol; 2002 Nov; 29(11):2435-41. PubMed ID: 12415605
[TBL] [Abstract][Full Text] [Related]
18. Personality and consultations with complementary and alternative medicine practitioners: a five-factor model investigation of the degree of use and motives.
Sirois FM; Purc-Stephenson RJ
J Altern Complement Med; 2008 Nov; 14(9):1151-8. PubMed ID: 18991517
[TBL] [Abstract][Full Text] [Related]
19. Complementary and alternative medicine use in adolescents with inflammatory bowel disease and juvenile idiopathic arthritis.
Nousiainen P; Merras-Salmio L; Aalto K; Kolho KL
BMC Complement Altern Med; 2014 Apr; 14():124. PubMed ID: 24708564
[TBL] [Abstract][Full Text] [Related]
20. Complementary medicine use in children and young adults with inflammatory bowel disease.
Heuschkel R; Afzal N; Wuerth A; Zurakowski D; Leichtner A; Kemper K; Tolia V; Bousvaros A
Am J Gastroenterol; 2002 Feb; 97(2):382-8. PubMed ID: 11866277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
